Clinical trial
A Multicenter, Prospective Observational Study to Evaluate the Injection Site Reactions of Synovian® Inj. in Patients With Osteoarthritis in the Knee
NCT04369261 is registered in ClinicalTrials.gov with LG Chem as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective Observational Study to Evaluate the Injection Site Reactions of Synovian® Inj. in Patients With Osteoarthritis in the Knee
- Lead sponsor
- LG Chem
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 9, 2018
- Completion date
- August 8, 2019
- Enrollment
- 1,949 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis in the knee